Clinical Trial Update: Azithromycin a Treatment for Pulmonary Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating azithromycin as a treatment for pulmonary sarcoidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis Pulmonary

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Sarcoidosis, Pulmonary | Phase 2 | Status: COMPLETED